TY - JOUR
T1 - Erratum
T2 - Long-term outcomes of early enzyme replacement therapy for mucopolysaccharidosis IV: Clinical case studies of two siblings (Diagnostics (2020) 10 (108) DOI: 10.3390/diagnostics10020108)
AU - Barak, Sharon
AU - Anikster, Yair
AU - Sarouk, Ifat
AU - Stern, Eve
AU - Eisenstein, Etzyona
AU - Yissar, Tamar
AU - Sherr-Lurie, Nir
AU - Raas-Rothschild, Annick
AU - Guttman, Dafna
N1 - Publisher Copyright:
© 2020 by the authors. Licensee MDPI, Basel, Switzerland.
PY - 2020/7
Y1 - 2020/7
N2 - The authors wish to make the following correction to this paper [1]: In the first paragraph of the Results section: “P1 and P2 started ERT with elosulfase alfa (VIMIZIM® by BioMarin
AB - The authors wish to make the following correction to this paper [1]: In the first paragraph of the Results section: “P1 and P2 started ERT with elosulfase alfa (VIMIZIM® by BioMarin
UR - http://www.scopus.com/inward/record.url?scp=85092655988&partnerID=8YFLogxK
U2 - 10.3390/diagnostics10070480
DO - 10.3390/diagnostics10070480
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.comment???
AN - SCOPUS:85092655988
VL - 10
JO - Diagnostics
JF - Diagnostics
SN - 2075-4418
IS - 7
M1 - 480
ER -